Art

J-GLOBAL ID：201902227236776088   Reference number：19A1167822

Overall survival (OS) in METEOR, a randomized phase 3 trial of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC).

進行腎細胞癌(RCC)の患者(pts)においてカボザチニブ(C)とエベロリムス(E)を比較したランダム化第三相臨床試験,METEORの全生存率(OS)

Author (20)： HUTSON Thomas (Baylor Univ. Medical Center, TX, USA) ,  POWLES Thomas (Queen Mary Univ. London, GBR) ,  ESCUDIER Bernard (Inst. Gustave Roussy, Villejuif, FRA) ,  TANNIR Nizar (Univ. Texas MD Anderson Cancer Center, TX, USA) ,  MAINWARING Paul (Univ. Queensland, Brisbane, AUS) ,  RINI Brian (Cleveland Clinic Taussig Cancer Inst., OH, USA) ,  HAMMERS Hans (Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, MD, USA) ,  DONSKOV Frede (Aarhus Univ. Hospital, Aarhus, DNK) ,  ROTH Bruce (Washington Univ. School of Medicine, MO, USA) ,  PELTOLA Katriina (Helsinki Univ. Hospital, Helsinki, FIN) ,  LEE Jae Lyun (Univ. Ulsan Coll. of Medicine, Seoul, KOR) ,  HENG Daniel (Univ. Calgary, AB, CAN) ,  SCHMIDINGER Manuela (Medical Univ. Vienna, Vienna, AUT) ,  AFTAB Dana (Exelixis, Inc., CA, USA) ,  HESSEL Colin (Exelixis, Inc., CA, USA) ,  SCHEFFOLD Christian (Exelixis, Inc., CA, USA) ,  SCHWAB Gisela (Exelixis, Inc., CA, USA) ,  PAL Sumanta (City of Hope, CA, USA) ,  MOTZER Robert (Memorial Sloan Kettering Cancer Center, NY, USA) ,  CHOUEIRI Toni (Dana-Farber/Brigham and Women’s Cancer Center, MA, USA)
Material： 日本泌尿器科学会総会(Web)
Volume： 107th  Page： ROMBUNNO.IS-40 (WEB ONLY)  Publication year： 2019 
JST Material Number： U1003A  Document type： Proceedings
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Advanced renal cell carcinoma ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1167822&from=J-GLOBAL&jstjournalNo=U1003A") }}

JST classification (2)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (2)： Everolimus ,  Cabozantinib

Terms in the title (10)： 進行腎細胞癌 ,  RCC ,  患者 ,  PTS ,  エベロリムス ,  ランダム化 ,  三相 ,  臨床試験 ,  全生存率 ,  Os